Janna Krol

Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer

Ursula McGovern, Richard E. Francis, Barrie Peck et al. · Molecular Cancer Therapeutics · 2009 · 132 citations · Full text

Medicine, Oncology, Pharmacology +15

The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells

Janna Krol, Richard E. Francis, André Albergaria et al. · Molecular Cancer Therapeutics · 2007 · 92 citations · Full text

Medicine, Oncology, Pharmacology +17

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer

Gabi W. van Pelt, Janna Krol, Irene M. Lips et al. · Clinical and Translational Radiation Oncology · 2019 · 42 citations · Full text

Medicine, Oncology, Chemotherapy +16

Loss of microglial ramification in microglia‐astrocyte cocultures: Involvement of adenylate cyclase, calcium, phosphatase, and G_i‐protein systems

Roger Kalla, Marion Bohatschek, Christian U.A. Kloss et al. · Glia · 2002 · 33 citations

Life Sciences, Neurobiology, Neuroscience +13

Inhibition of Intraperitoneal Tumor Growth of Human Ovarian Cancer Cells by Bi- and Trifunctional Inhibitors of Tumor-Associated Proteolytic Systems

Janna Krol, Charlotte Kopitz, Angela Kirschenhofer et al. · Biological Chemistry · 2003 · 20 citations

Medicine, Oncology, Pharmacology +12